|
Project description
The proposed project consists of a loan to
NPO Petrovax Pharm, a Russian niche pharmaceutical company based in Moscow.
The loan will be used to finance construction of a green field facility near
Moscow to manufacture a new generation vaccines, e.g. influenza vaccine, for
the Russian and CIS market. The Project is a result of collaboration efforts
of Petrovax and a major international pharmaceutical player, Solvay, which is
a leading European chemicals and pharmaceuticals group. Solvay will provide
project implementation and management support.
Environmental, health and safety issues
The Project has been
categorised B/0. Environmental, health and safety risks associated with
construction and operation of this pharmaceutical plant are not significant.
The Bank’s environmental analysis has been based on the Environmental Impact
Assessment (August 2004) prepared by an independent environmental consultant
on behalf of the client. EBRD’s Initial Environmental Examination, carried out
by ED staff member in May 2004, indicated that there are no environmental
sensitivities associated with the project. The site was chosen among several
alternatives on the basis of its good transport links and low ecological
value. The proposed project site is adjacent to the existing motorway Moscow-
Serpukhov and although the land plot it is formally classified as
“agricultural”, there are no crops that have ever been grown on it. There are
about twenty country houses located in the vicinity of the site (ca. 100 m
away). However, this fact does not represent potential issue of concern as the
residents have been informed about the future plans and have not expressed any
objections to the project due to the fact that the required sanitary
protection zone of 50 m will be observed. The nearest local river (Pakhra) is
1 km away from the project site. The Bank's environmental due diligence
confirmed that the new plant will be built in accordance with applicable
national environmental, health and safety requirements, with Good
Manufacturing Practice (GMP) standards and generally in line with the World
Bank Pollution Prevention Guidelines for Pharmaceuticals Manufacturing. No
stand alone environmental action plan is required as the project design
provides for minimisation of the environmental, health and safety impacts
associated with construction and operation of the plant.
This Environmental Review Summary is being released locally by the client in
accordance with EBRD's Environmental Policy and Procedures.
Air emissions
Key air emissions will include ethyl alcohol
(from the antiseptic maintance of equipment surfaces); peroxide (from
cleaning); nitrogen and carbon oxides, benzopyrene (from gas-fired hobs and
boiler); volatile organic components, benzene hydrocarbons, sulphur oxides,
ash (from the car park and garage). All the emissions will be within the
maximum permissible emissions levels calculated on the basis of the applicable
national standards for the maximum permissible concentrations (MPC) of the
corresponding pollutants in the atmospheric air.
Effluent discharges
There will be no polluted process
wastewaters as the project design envisaged closed loop water system (95% of
water will be recirculated). The waste waters from the maintenance operation
can be classified as sanitary and will be discharged into the municipal sewer
system. The stormwater will be sent via the drainage system to on-site waste
water treatment facilities and than discharged onto the relief/used in
watering the site.
Solid and hazardous waste management
Key types of solid and
hazardous waste from the production process and general operating practices
will include mercury lamps, packaging waste, filters, rubber cuttings,
polymeric waste (plastic containers), metal scrap, cloth, waste paper and
solid municipal waste. All these will be stored temporarily on-site in
designated areas and than either handed over to subcontractors for further
recycling and re-use, as appropriate, or transported to a municipal landfill
in accordance with the local waste managements regulations.
Noise
The noise levels resulting from the production facilities
in the distance of 50-100 m from the boundary of the plant's sanitary
protection zone (in the area of the country houses cluster) will be 20dBa,
which is well below the applicable World Bank Guidelines (55 and 45 dBA during
the day and at night respectively for the residential areas).
Emergency response planning and preparedness
In the event of an
accident or emergency the machinery in the plant shuts down automatically.
The plant will co-ordinate with the municipal fire service to ensure a timely
and adequate response to any emergency situation. Emergency response plan
will be developed in a due course and will be reviewed by the Bank upon its
submission.
Employee health and safety
Health and safety issues are,
likewise, well recognised and managed by the client. Training will be provided
when new employees start and repeated at regular intervals during the year.
Health and safety controllers will be in charge of monitoring compliance with
health and safety requirements and there will be a variety of sanctions which
can be applied for non-compliance with health and safety rules.
Environmental opportunities
There is likely to be a range of
positive environmental opportunities associated with this project particularly
those in relation to the proposed development of Good Manufacturing Practice
(GMP) as well as the ISO 14001 and OHSAS18001 standards adhered to by Solvay,
which will provide the implementation and management support for the project.
Monitoring and compliance
This will take form of annual
environmental reports and periodic monitoring visits of the Bank’s ED staff as
required.
|
